Taysha Gene Therapies (TSHA) Misses Q2 EPS by 7c, beats revenue

Go back to Taysha Gene Therapies (TSHA) Misses Q2 EPS by 7c, beats revenue
(NASDAQ: TSHA) Delayed: 6.64 +0.22 (3.43%)
Previous Close $6.42    52 Week High
Open $6.50    52 Week Low
Day High $6.70    P/E N/A 
Day Low $6.47    EPS
Volume 1,855,055